Abivax SA (ABVX)
124.03
+4.13
(+3.44%)
USD |
NASDAQ |
May 21, 16:00
124.29
+0.26
(+0.21%)
After-Hours: 19:59
Abivax Shareholders Equity (Quarterly) : 534.62M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| DBV Technologies SA | 207.90M |
| Nicox SA | -- |
| Cellectis SA | 59.92M |
| Transgene SA | -- |
| Innate Pharma SA | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 686.28M |
| Total Liabilities (Quarterly) | 151.66M |
| Debt to Equity Ratio | 0.0705 |
| Current Ratio | 8.747 |
| Net Debt Paydown Yield | 0.14% |